ClinicalTrials.Veeva

Menu

Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline

L

Lei Li

Status

Unknown

Conditions

Chemotherapy-induced Nausea and Vomiting
Gynecologic Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT03740672
GO-CINV

Details and patient eligibility

About

This study aims to investigate the adherence to the antiemesis NCCN guideline in Chinese patients of gynecologic malignancies, who are given chemotherapy treatment. The risk of chemotherapy induced nausea and vomiting (CINV) is calculated by the questionnaire supported by the website "CINV Risk Assessment" (http://www.riskcinv.org/).

Enrollment

1,000 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Good performance status
  • Aged 18 years or older
  • Signed an approved informed consents

Exclusion criteria

  • Not meeting all of the inclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Lei Li, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems